Penumbra Return on Investment 2014-2025 | PEN
Current and historical return on investment (ROI) values for Penumbra (PEN) over the last 10 years.
| Penumbra ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2025-06-30 | $0.16B | $1.32B | 13.11% |
| 2025-03-31 | $0.04B | $1.23B | 3.14% |
| 2024-12-31 | $0.01B | $1.17B | 0.76% |
| 2024-09-30 | $0.00B | $1.13B | 0.08% |
| 2024-06-30 | $-0.02B | $1.18B | -1.77% |
| 2024-03-31 | $0.08B | $1.23B | 6.71% |
| 2023-12-31 | $0.07B | $1.20B | 6.62% |
| 2023-09-30 | $0.04B | $1.13B | 4.10% |
| 2023-06-30 | $0.04B | $1.09B | 3.46% |
| 2023-03-31 | $0.02B | $1.05B | 1.77% |
| 2022-12-31 | $0.01B | $1.02B | 0.60% |
| 2022-09-30 | $-0.04B | $1.00B | -3.94% |
| 2022-06-30 | $-0.04B | $1.00B | -3.81% |
| 2022-03-31 | $-0.03B | $0.99B | -2.96% |
| 2021-12-31 | $-0.01B | $0.98B | -1.04% |
| 2021-09-30 | $0.03B | $0.71B | 4.36% |
| 2021-06-30 | $0.00B | $0.70B | 0.15% |
| 2021-03-31 | $-0.03B | $0.68B | -4.09% |
| 2020-12-31 | $-0.04B | $0.67B | -6.30% |
| 2020-09-30 | $-0.03B | $0.65B | -4.48% |
| 2020-06-30 | $0.01B | $0.65B | 1.67% |
| 2020-03-31 | $0.04B | $0.52B | 14.80% |
| 2019-12-31 | $0.05B | $0.51B | 37.50% |
| 2019-09-30 | $0.04B | 0.00% | |
| 2019-06-30 | $0.01B | 0.00% | |
| 2019-03-31 | $0.01B | 0.00% | |
| 2018-12-31 | $0.00B | 0.00% | |
| 2018-09-30 | $0.00B | 0.00% | |
| 2018-06-30 | $0.02B | 0.00% | |
| 2018-03-31 | $0.01B | 0.00% | |
| 2017-12-31 | $0.00B | 0.00% | |
| 2017-09-30 | $0.00B | 0.00% | |
| 2017-06-30 | $-0.01B | 0.00% | |
| 2017-03-31 | $-0.01B | 0.00% | |
| 2016-12-31 | $0.00B | 0.00% | |
| 2016-09-30 | $0.00B | 0.00% | |
| 2016-06-30 | $0.01B | 0.00% | |
| 2016-03-31 | $0.00B | 0.00% | |
| 2015-12-31 | $0.00B | 0.00% | |
| 2015-06-30 | $0.00B | 0.00% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $10.953B | $1.195B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $220.349B | 26.18 |
| Intuitive Surgical (ISRG) | United States | $205.110B | 80.25 |
| IDEXX Laboratories (IDXX) | United States | $56.892B | 56.50 |
| Edwards Lifesciences (EW) | United States | $49.418B | 33.14 |
| Alcon (ALC) | Switzerland | $38.157B | 25.79 |
| IQVIA Holdings (IQV) | United States | $37.216B | 20.75 |
| Mettler-Toledo (MTD) | United States | $29.520B | 34.54 |
| STERIS (STE) | Ireland | $26.176B | 27.02 |
| Waters (WAT) | United States | $22.989B | 30.41 |
| DexCom (DXCM) | United States | $22.672B | 31.25 |
| Hologic (HOLX) | United States | $16.592B | 17.47 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.147B | 0.00 |
| Globus Medical (GMED) | United States | $11.472B | 23.86 |
| Masimo (MASI) | United States | $7.879B | 25.25 |
| Sysmex ADR (SSMXY) | Japan | $6.616B | 21.02 |
| Glaukos (GKOS) | United States | $5.163B | 0.00 |
| Teleflex (TFX) | United States | $4.961B | 7.91 |
| TransMedics (TMDX) | United States | $4.174B | 49.45 |
| Veracyte (VCYT) | United States | $3.372B | 38.43 |
| Alphatec Holdings (ATEC) | United States | $3.078B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.877B | 15.54 |
| Integer Holdings (ITGR) | United States | $2.446B | 11.48 |
| Artivion (AORT) | United States | $2.220B | 101.87 |
| Nihon Kohden (NHNKY) | Japan | $1.815B | 15.84 |
| PROCEPT BioRobotics (PRCT) | United States | $1.751B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $1.710B | 16.57 |
| Beta Bionics (BBNX) | United States | $1.269B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.188B | 0.00 |
| AxoGen (AXGN) | United States | $1.128B | 0.00 |
| IRadimed (IRMD) | United States | $1.077B | 51.30 |
| Pulse Biosciences (PLSE) | United States | $1.038B | 0.00 |
| OPKO Health (OPK) | United States | $1.021B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.960B | 5.20 |
| SiBone (SIBN) | United States | $0.791B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.607B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.562B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.561B | 32.60 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.541B | 10.80 |
| AngioDynamics (ANGO) | United States | $0.520B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.495B | 0.00 |
| NeuroPace (NPCE) | United States | $0.449B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.442B | 12.20 |
| OrthoPediatrics (KIDS) | United States | $0.432B | 0.00 |
| RxSight (RXST) | United States | $0.421B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.414B | 3.25 |
| Sight Sciences (SGHT) | United States | $0.372B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.334B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.312B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.304B | 50.71 |
| CVRx (CVRX) | United States | $0.258B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.214B | 0.00 |
| 908 Devices (MASS) | United States | $0.213B | 0.00 |
| Inogen (INGN) | United States | $0.190B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.166B | 0.00 |
| Neuronetics (STIM) | United States | $0.151B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.145B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.140B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.139B | 0.00 |
| Accuray (ARAY) | United States | $0.133B | 0.00 |
| LENSAR (LNSR) | United States | $0.125B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.092B | 0.00 |
| Hyperfine (HYPR) | United States | $0.086B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.076B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.075B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.069B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.044B | 0.00 | |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.018B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.009B | 0.00 |
| Solana (HSDT) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.53 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |